Literature DB >> 31811316

Maternal schizophrenia and adverse birth outcomes: what mediates the risk?

Simone N Vigod1,2,3, Kinwah Fung4, Abigail Amartey4, Emily Bartsch5, Reema Felemban5, Natasha Saunders5,4,6, Astrid Guttmann5,4,6, Maria Chiu5,4, Lucy C Barker7,5,4, Paul Kurdyak5,4,8, Hilary K Brown7,5,4.   

Abstract

PURPOSE: Maternal schizophrenia is associated with adverse birth outcomes, but the reasons for this remain unclear. In a population-based cohort of infants born to women with schizophrenia, we determined the occurrence of key perinatal outcomes and explored whether factors identifiable in our datasets explained any elevated risk.
METHODS: Using population-level health administrative data linked to clinical birth-registry data in Ontario, Canada (2006-2011), we examined the relative risk (RR) of preterm birth (< 37 weeks), small for gestational age (SGA), and Apgar scores < 8 in infants of women with schizophrenia (n = 4279) versus infants of unaffected women (n = 286,147). Generalized estimating equations determined whether reproductive history, maternal health conditions, pregnancy exposures, and complications explained elevated RRs.
RESULTS: Among infants of women with schizophrenia, risk was higher for prematurity (11.4% vs. 6.9%, aRR 1.64, 95% CI 1.51-1.79), SGA (3.5% vs. 2.5%, aRR 1.40, 95% CI 1.20-1.64), and Apgar score < 8 at 1 (19.0% vs. 12.8%, aRR 1.49, 95% CI 1.40-1.59) and 5 min (5.6% vs. 3.0%, aRR 1.90, 95% CI 1.68-2.16). Smoking, fourfold more common among women with schizophrenia, was the variable that explained the greatest proportion of the elevated aRR for prematurity (9.9%), SGA (28.7%), and Apgar < 8 at 1 and 5 min (9.8%, 5.6%). Illicit substance use, certain reproductive history variables, and pregnancy complications also contributed to the elevated aRR for preterm birth.
CONCLUSIONS: Elevated risks of preterm birth, SGA, and low Apgar scores in infants of women with schizophrenia are partly explained by potentially modifiable factors such as smoking and illicit drug use, suggesting opportunities for targeted intervention.

Entities:  

Keywords:  Apgar; Perinatal outcomes; Preterm birth; Risk factors; Schizophrenia; Small for gestational age

Year:  2019        PMID: 31811316     DOI: 10.1007/s00127-019-01814-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  64 in total

1.  Prevention inherent in services for women with schizophrenia.

Authors:  Mary V Seeman
Journal:  Can J Psychiatry       Date:  2008-05       Impact factor: 4.356

Review 2.  Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses.

Authors:  Katy Gouin; Kellie Murphy; Prakesh S Shah
Journal:  Am J Obstet Gynecol       Date:  2011-01-22       Impact factor: 8.661

Review 3.  Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice.

Authors:  Christine Dunkel Schetter; Lynlee Tanner
Journal:  Curr Opin Psychiatry       Date:  2012-03       Impact factor: 4.741

4.  Mother's anxiety and depression and associated risk factors during early pregnancy: effects on fetal growth and activity at 20-22 weeks of gestation.

Authors:  Ana Conde; Bárbara Figueiredo; Iva Tendais; César Teixeira; Raquel Costa; Alexandra Pacheco; Maria Ceu Rodrigues; Raul Nogueira
Journal:  J Psychosom Obstet Gynaecol       Date:  2010-06       Impact factor: 2.949

5.  Placental abruption and adverse perinatal outcomes.

Authors:  C V Ananth; G S Berkowitz; D A Savitz; R H Lapinski
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

6.  Smoking and mental illness: A population-based prevalence study.

Authors:  K Lasser; J W Boyd; S Woolhandler; D U Himmelstein; D McCormick; D H Bor
Journal:  JAMA       Date:  2000 Nov 22-29       Impact factor: 56.272

7.  SMI life goals: description of a randomized trial of a collaborative care model to improve outcomes for persons with serious mental illness.

Authors:  Amy M Kilbourne; Margretta Bramlet; Michelle M Barbaresso; Kristina M Nord; David E Goodrich; Zongshan Lai; Edward P Post; Daniel Almirall; Lilia Verchinina; Sonia A Duffy; Mark S Bauer
Journal:  Contemp Clin Trials       Date:  2014-07-30       Impact factor: 2.226

8.  Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder.

Authors:  Jaana M Suvisaari; Virpi Taxell-Lassas; Maiju Pankakoski; Jari K Haukka; Jouko K Lönnqvist; Laura T Häkkinen
Journal:  Schizophr Bull       Date:  2012-09-20       Impact factor: 9.306

9.  Validation of a case definition to define hypertension using administrative data.

Authors:  Hude Quan; Nadia Khan; Brenda R Hemmelgarn; Karen Tu; Guanmin Chen; Norm Campbell; Michael D Hill; William A Ghali; Finlay A McAlister
Journal:  Hypertension       Date:  2009-10-26       Impact factor: 10.190

10.  The Role of Stress in Brain Development: The Gestational Environment's Long-Term Effects on the Brain.

Authors:  Claudia Buss; Sonja Entringer; James M Swanson; Pathik D Wadhwa
Journal:  Cerebrum       Date:  2012-04-25
View more
  6 in total

1.  Antipsychotic utilization patterns in pregnant women with psychotic disorders: a 16-year population-based cohort study.

Authors:  Jenny Wai Yiu Law; Joe Kwun Nam Chan; Corine Sau Man Wong; Eric Yu Hai Chen; Wing Chung Chang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-06       Impact factor: 5.270

2.  Schizophrenia pregnancies should be given greater health priority in the global health agenda: results from a large-scale meta-analysis of 43,611 deliveries of women with schizophrenia and 40,948,272 controls.

Authors:  Damien Etchecopar-Etchart; Roxane Mignon; Laurent Boyer; Guillaume Fond
Journal:  Mol Psychiatry       Date:  2022-07-08       Impact factor: 13.437

3.  Associations between pre-pregnancy psychosocial risk factors and infant outcomes: a population-based cohort study in England.

Authors:  Katie Harron; Ruth Gilbert; Jamie Fagg; Astrid Guttmann; Jan van der Meulen
Journal:  Lancet Public Health       Date:  2021-02

4.  Do Current Measures of Polygenic Risk for Mental Disorders Contribute to Population Variance in Mental Health?

Authors:  Anne Marsman; Lotta-Katrin Pries; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Gunter Kenis; Bochao D Lin; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz; Jim van Os
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

5.  Severe mental illness and pregnancy outcomes in Australia. A population-based study of 595 792 singleton births 2009-2016.

Authors:  Kristina Edvardsson; Elizabeth Hughes; Beverley Copnell; Ingrid Mogren; Don Vicendese; Richard Gray
Journal:  PLoS One       Date:  2022-02-28       Impact factor: 3.240

6.  Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study.

Authors:  Óskar Hálfdánarson; Jacqueline M Cohen; Øystein Karlstad; Carolyn E Cesta; Marte-Helene Bjørk; Siri Eldevik Håberg; Kristjana Einarsdóttir; Kari Furu; Mika Gissler; Vidar Hjellvik; Helle Kieler; Maarit K Leinonen; Mette Nørgaard; Buket Öztürk Essen; Sinna Pilgaard Ulrichsen; Johan Reutfors; Helga Zoega
Journal:  Evid Based Ment Health       Date:  2021-11-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.